PAP modulations in Daudi cells and Molt-3 cells treated with etoposide are mutually associated with morphological evidence of apoptosis

International Journal of Biological Markers

Volumn 19, Issue 3, 2004, Pages 203-212

  Thomadaki, E ^a   Havredaki, M ^a   Tsiapalis, C M ^b  

^a INSTITUTE OF NANOSCIENCE AND NANOTECHNOLOGY   (Greece)

^b SAINT SAVVAS HOSPITAL   (Greece)

Author keywords

Apoptosis; Daudi; DNA fragmentation; Etoposide; Leukemia; Molt 3; PAP; Poly(A) polymerase; Polyadenylation; m

Indexed keywords

CASPASE 6; DNA FRAGMENT; ETOPOSIDE; ISOENZYME; MESSENGER RNA; POLYNUCLEOTIDE ADENYLYLTRANSFERASE;

APOPTOSIS; ARTICLE; B LYMPHOCYTE; CELL CYCLE; CELL NUCLEUS; CELL STRUCTURE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DOWN REGULATION; DRUG SENSITIVITY; ENZYME ACTIVITY; ENZYME REGULATION; HUMAN; HUMAN CELL; POLYADENYLATION; RNA CLEAVAGE; RNA STABILITY; T LYMPHOCYTE;

EID: 6444221836     PISSN: 03936155     EISSN: None     Source Type: Journal    
DOI: 10.5301/JBM.2008.4446     Document Type: Article

References (50)

1. Robertson JD, Fadeel B, Zhivotovsky B, Orrenius S. "Centennial" Nobel Conference on apoptosis and human disease. Cell Death Differ 2002; 9: 468-75.
2. Lawen A. Apoptosis-an introduction. BioEssays 2003; 25: 888-96.
3. Häcker G. The morphology of apoptosis. Cell Tissue Res 2000; 301: 5-17.
4. Bratton SB, MacFarlane M, Cain K, Cohen GM. Protein complexes activate distinct caspase cascades in death receptor and stress-induced apoptosis. Exp Cell Res 2000; 256: 27-33.
5. Strasser A, O'Connor L, Dixit VM. Apoptosis signalling. Annu Rev Biochem 2000; 69: 217-45.
6. Bamford M, Walkinshaw G, Brown R. Therapeutic applications of apoptosis research. Exp Cell Res 2000; 256: 1-11.
7. Hannun YA. Apoptosis and the dilemma of cancer chemotherapy. Blood 1997; 89: 1845-53.
8. Atabasides H, Tsiapalis CM, Havredaki M. Dephosphorylation, proteolysis and reduced activity of poly(A) polymerase associated with U937 cell apoptosis. Exp Cell Res 1998; 244: 433-40.
9. Balatsos NA, Lallas G, Havredaki M, Tsiapalis CM. Drug action on poly(A) polymerase activity and isoforms during U937 cell apoptosis. J Exp Clin Cancer Res 2001; 20: 63-9.
10. Balatsos NA, Havredaki M, Tsiapalis CM. Anticancer drug action on poly(A) polymerase activity and isoforms during HeLa and WISH cell apoptosis. Int J Biol Markers 2000; 15: 171-8.
11. Balatsos NA, Havredaki M, Tsiapalis CM. Early 5-FU-induced changes of poly(A) polymerase in HeLa and WISH cells. Int J Biol Markers 2000; 15: 294-9.
12. Mouland AJ, Coady M, Yao XJ, Cohen EA. Hypophosphorylation of poly(A) polymerase and increased polyadenylation activity are associated with human immunodeficiency virus type 1 Vpr expression. Virology 2002; 292: 321-30.
13. Gunderson SI, Beyer K, Martin G, Keller W, Boelens WC, Mattaj IW. The human U1A snRNP regulates polyadenylation via a direct interaction with poly(A) polymerase. Cell 1994; 76: 531-41.
14. Whale E, Kuhn U. The mechanism of 3′ cleavage and polyadenylation of eukaryotic pre-mRNA. Nucleic Acid Res 1997; 57: 41-67.
15. Colgan FD, Manley LJ. Mechanisms and regulation of mRNA polyadenylation. Genes Dev 1997; 11: 2755-66.
16. Zhao J, Hyman L, Moore C. Formation of mRNA 3′ ends in eukaryotes: mechanism, regulation and interrelationships with other steps in mRNA synthesis. Microbiol Mol Biol Rev 1999; 63: 405-45.
17. Wahle E, Ruegsegger U. 3′-end processing of pre-mRNA in eukaryotes. FEMS Microbiol Rev 1999; 23: 277-95.
18. Barabino SML, Keller W. Last but not least: regulated poly(A) tail formation. Cell 1999; 99: 9-11.
19. Proudfoot N. Connecting transcription to mRNA processing. Trends Biochem Sci 2000; 25: 290-3.
20. Holm L, Sander C. DNA polymerase β belongs to an ancient nucleotidyltransferase family. Trends Biochem Sci 1995; 20: 345-7.
21. Thuresson AC. Regulation of mammalian Poly(A) polymerase activity. Uppsala: Uppsala University, 2002.
22. Raabe T, Bollum FJ, Manley JL. Primary structure and expression of bovine poly(A) polymerase. Nature 1991; 353: 229-34.
23. Wahle E, Martin G, Schiltz E, Keller W. Isolation and expression of cDNA clones encoding mammalian poly(A) polymerase. EMBO J 1991; 10: 4251-7.
24. Bond GL, Prives C, Manley JL. Poly(A) polymerase phosphorylation is dependent on novel interactions with cyclins. Mol Cell Biol 2000; 20: 5310-20.
25. Colgan F, Murthy KGK, Prives C, Manley JL. Cell-cycle related regulation of poly(A) polymerase by phosphorylation. Nature 1996; 384: 282-5.
26. Kashiwabara S, Zhuang T, Yamagata K, Noguchi J, Fukamizu A, Baba T. Identification of a novel isoform of poly(A) polymerase, TPAP, specifically present in the cytoplasm of spermatogenic cells. Dev Biol 2000; 228: 106-15.
27. Lee YJ, Lee Y, Chung JH. An intronless gene encoding a poly(A) polymerase is specifically expressed in testis. FEBS Lett 2000; 487: 287-92.
28. Topalian SL, Kaneko S, Gonzales MI, Bond GL, Ward Y, Manley JL. Identification and functional characterization of neo-poly(A) polymerase, an RNA processing enzyme over-expressed in human tumors. Mol Cell Biol 2001; 21: 5614-23.
29. Kyriakopoulou CB, Nordvarg H, Virtanen A. A novel nuclear human poly(A) polymerase (PAP), PAPγ. J Biol Chem 2001; 276: 33504-11.
30. Saitoch S, Chabes A, McDonald WH, Thelander L, Yates RJ, Russell P. Cid13 is a cytoplasmic poly(A) polymerase that regulates ribonucleotide reductase mRNA. Cell 2002; 109: 563-73.
31. Prokipcak RD, Raouf A, Lee C. The AU-rich 3′ untranslated region of human Mdr1 mRNA is an inefficient destabilizer. Biochem Biophys Res Commun 1999; 11: 627-34.
32. Lapucci A, Donnini M, Papucci L, et al. AUF1 is a bcl-2 A+U-rich element-binding protein involved in bcl-2 mRNA destabilizing during apoptosis. J Biol Chem 2002; 277: 16139-46.
33. Kim H, You S, Foster LK, Farris J, Foster DN. The rapid destabilization of p53 mRNA in immortal chicken embryo fibroblast cells. Oncogene 2001; 20: 5118-23.
34. Casciola-Rosen LA, Miller KD, Anhalt GJ, Rossen A. Specific cleavage of the 70 kDa protein component of the U1 small nuclear ribonucleoprotein is a characteristic biochemical feature of apoptotic cell death. J Biol Chem 1994; 269: 30757-60.
35. Bary MA, Behnke CA, Eastman A. Activation of programmed cell death (apoptosis) by cisplatin, other anti-cancer drugs, toxins and hyperthermia. Biochem Pharmacol 1990; 40: 2352-62.
36. Lazebnic YA, Cole S, Cooke CA, Nelson WG, Earnshaw WC. Nuclear events of apoptosis in cell-free mitotic extracts: A model system for analysis of the active phase of apoptosis. J Cell Biol 1993; 123: 7-22.
37. Mosmann T. Rapid colorimetric assay for the cellular growth and survival: application and cyctotoxic assays. J Immunol Methods 1983; 65: 55-63.
38. Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970; 227: 680-5.
39. Burnette NW. "Western blotting": electrophoretic transfer of proteins from sodium dodecyl sulphate-polyacrylamide gels to unmodified nitrocellulose and radiographic detection with antibody and radioiodinated protein A. Anal Biochem 1981; 112: 195-203.
40. Bollum FJ, Chang LMS, Tsiapalis CM, Dorson JW. Nucleotide polymerizing enzymes from calf thymus gland. Methods Enzymol 1974; 29: 70-81.
41. Didelot C, Mirjolet JF, Barberi-Heyob M, Ramacci C, Merlin JL. Radiation could induce p53-independent and cell cycle-unrelated apoptosis in 5-fluorouracil radiosensitized head and neck carcinoma cells. Can J Physiol Pharmacol 2002; 80: 638-43.
42. Chou RH, Huang H. Restoration of p53 tumor suppressor pathway in human cervical carcinoma cells by sodium arsenate. Biochem Biophys Res Commun 2002; 293: 298-306.
43. Polla BS, Kantengwa S, Francois D, et al. Mitochondria are selective targets for the protective effects of heat shock against oxidative injury. Proc Natl Acad Sci 1996; 93: 6458-63.
44. Salvioli S, Ardizzoni A, Franceschi C, Cossarizza A. JC-1, but not DiOC6(3) or rhodamine 123, is a reliable fluorescent probe to assess Δψm changes in intact cells: implications for studies on mitochondrial functionality during apoptosis. FEBS Lett 1997; 411: 77-82.
45. Komatsu N, Oda T, Muramatsu T. Involvement of both caspase-like protases and serine protesases in apoptotic cell death induced by ricin, modeccin, diphtheria toxin and pseudomonas toxin. J Biochem 1998; 124: 1038-44.
46. Beere HM, Chresta CM, Alejo-Herberg A, et al. Investigation of the mechanism of higher order chromatin fragmentation observed in drug-induced apoptosis. Mol Pharmac 1995; 47: 986-96.
47. Sleiman RJ, Stewart BW. Early caspase activation in leukemic cells subject to etoposide-induced G2-M arrest: evidence of commitment to apoptosis rather than mitotic cell death. Clin Cancer Res 2000; 6: 3756-65.
48. Kawabata Y, Hirokawa M, Kitabayashi A, Horiuchi T, Kuroki J. Defective apoptotic signal transduction pathway downstream of caspase-3 in human B-lymphoma cells: a novel mechanism of nuclear apoptosis resistance. Blood 1999; 94: 3523-30.
49. Luciano F, Ricci J-E, Herrant M, et al. T and B leukemic cell lines exhibit different requirements for cell death: correlation between caspase activation, DFF40/DFF45 expression, DNA fragmentation and apoptosis in T cells but not in Burkitt's lymphoma. Leukemia 2002; 16: 700-7.
50. Catchpoole DR, Stewart BW. Etoposide-induced cytotoxicity in two human T-cell leukemic lines: delayed loss of membrane permeability rather than DNA fragmentation as an indicator of programmed cell death. Cancer Res 1993; 53: 4287-96.